Vanguard Personalized Indexing Management
KYMR icon

Vanguard Personalized Indexing Management’s Kymera Therapeutics KYMR Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$738K Sell
6,433
-44
-0.7% -$3.78K 0.01% 1167
2026
Q1 		$539K Buy
6,477
+2,831
+78% +$224K 0.01% 1265
2025
Q4 		$284K Buy
+3,646
New +$246K ﹤0.01% 1555

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Vanguard Personalized Indexing Management's KYMR Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Kymera Therapeutics (KYMR) stake by 0.68% in Q2 2026, selling an estimated $3.78K and leaving 6,433 shares worth $738K. The position accounts for 0.01% of the portfolio, ranked #1167.

Vanguard Personalized Indexing Management first reported a position in KYMR in Q4 2025 and has held it in 3 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Vanguard Personalized Indexing Management held 6,433 shares of Kymera Therapeutics worth $738K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 44 Kymera Therapeutics shares in Q2 2026, an estimated $3.78K.
  • Kymera Therapeutics made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1167 holding.
  • Vanguard Personalized Indexing Management first reported a position in Kymera Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.